{"schema_version":"secwatch.filing_event.v1","accession":"0001447028-24-000066","form_type":"8-K","ticker":"ABUS","cik":"0001447028","company_name":"Arbutus Biopharma Corp","filed_at":"2024-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.093775+00:00","generated_at":"2026-05-31T13:03:34.020100+00:00","sec_items":["7.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Arbutus and Moderna agree to extend patent trial schedule to Sept 2025","bullets":["Arbutus, Genevant filed stipulation with Moderna extending case schedule in COVID-19 vaccine patent suit.","Parties request trial start moved to September 24, 2025, subject to court approval.","Lawsuit seeks damages for patent infringement in manufacture and sale of MRNA-1273.","Stipulation cites need to accommodate outstanding discovery from Moderna and third parties."],"urls":{"canonical":"https://secwatch.observer/filing/0001447028-24-000066","json":"https://secwatch.observer/filing/0001447028-24-000066.json","markdown":"https://secwatch.observer/filing/0001447028-24-000066.md","text":"https://secwatch.observer/filing/0001447028-24-000066.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000066/0001447028-24-000066-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000066/abus-20240805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:03:34.020100+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}